Trials / Sponsors / Invivoscribe, Inc.
Invivoscribe, Inc.
Industry · 4 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx TRG Assay T-Cell Lymphoproliferative Disorder | — | 2025-06-02 |
| Recruiting | The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research Hematologic Diseases | — | 2024-03-30 |
| Completed | Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx IGH Assay B-Cell Lymphoproliferative Disorder | — | 2024-01-02 |
| Unknown | The Use of Peripheral Blood Specimens From Patients Suspected of Having SARS-CoV-2 Infections in Research Stud SARS-CoV-2 | — | 2020-06-01 |